BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19224632)

  • 1. MOG(35-55) i.v suppresses experimental autoimmune encephalomyelitis partially through modulation of Th17 and JAK/STAT pathways.
    Jiang Z; Li H; Fitzgerald DC; Zhang GX; Rostami A
    Eur J Immunol; 2009 Mar; 39(3):789-99. PubMed ID: 19224632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ICOS deficiency results in exacerbated IL-17 mediated experimental autoimmune encephalomyelitis.
    Galicia G; Kasran A; Uyttenhove C; De Swert K; Van Snick J; Ceuppens JL
    J Clin Immunol; 2009 Jul; 29(4):426-33. PubMed ID: 19291374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver X receptor agonist regulation of Th17 lymphocyte function in autoimmunity.
    Xu J; Wagoner G; Douglas JC; Drew PD
    J Leukoc Biol; 2009 Aug; 86(2):401-9. PubMed ID: 19406833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic role of interferon-γ in experimental autoimmune encephalomyelitis is mediated through a tolerogenic subset of splenic CD11b
    Arellano G; Acuña E; Loda E; Moore L; Tichauer JE; Castillo C; Vergara F; Burgos PI; Penaloza-MacMaster P; Miller SD; Naves R
    J Neuroinflammation; 2024 May; 21(1):144. PubMed ID: 38822334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymph node-derived donor encephalitogenic CD4+ T cells in C57BL/6 mice adoptive transfer experimental autoimmune encephalomyelitis highly express GM-CSF and T-bet.
    Cravens PD; Hussain RZ; Zacharias TE; Ben LH; Herndon E; Vinnakota R; Lambracht-Washington D; Nessler S; Zamvil SS; Eagar TN; Stüve O
    J Neuroinflammation; 2011 Jun; 8():73. PubMed ID: 21702922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutting edge: the pathogenicity of IFN-γ-producing Th17 cells is independent of T-bet.
    Duhen R; Glatigny S; Arbelaez CA; Blair TC; Oukka M; Bettelli E
    J Immunol; 2013 May; 190(9):4478-82. PubMed ID: 23543757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stat4 isoforms differentially regulate inflammation and demyelination in experimental allergic encephalomyelitis.
    Mo C; Chearwae W; O'Malley JT; Adams SM; Kanakasabai S; Walline CC; Stritesky GL; Good SR; Perumal NB; Kaplan MH; Bright JJ
    J Immunol; 2008 Oct; 181(8):5681-90. PubMed ID: 18832727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase C θ regulates the phenotype of murine CD4+ Th17 cells.
    Wachowicz K; Hermann-Kleiter N; Meisel M; Siegmund K; Thuille N; Baier G
    PLoS One; 2014; 9(5):e96401. PubMed ID: 24788550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective depletion of CD11c
    Wang L; Li Z; Ciric B; Safavi F; Zhang GX; Rostami A
    Eur J Immunol; 2016 Oct; 46(10):2454-2466. PubMed ID: 27338697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BJ-2266 ameliorates experimental autoimmune encephalomyelitis through down-regulation of the JAK/STAT signaling pathway.
    You Z; Timilshina M; Jeong BS; Chang JH
    Eur J Immunol; 2017 Sep; 47(9):1488-1500. PubMed ID: 28681958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.
    Mony JT; Khorooshi R; Owens T
    Mult Scler; 2014 Sep; 20(10):1312-21. PubMed ID: 24552747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-γ limits Th9-mediated autoimmune inflammation through dendritic cell modulation of IL-27.
    Murugaiyan G; Beynon V; Pires Da Cunha A; Joller N; Weiner HL
    J Immunol; 2012 Dec; 189(11):5277-83. PubMed ID: 23125412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tripchlorolide ameliorates experimental autoimmune encephalomyelitis by down-regulating ERK1/2-NF-κB and JAK/STAT signaling pathways.
    Zhang J; Zeng YQ; Zhang J; Pan XD; Kang DY; Huang TW; Chen XC
    J Neurochem; 2015 Apr; 133(1):104-12. PubMed ID: 25662403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of experimental autoimmune encephalomyelitis by plumbagin through down-regulation of JAK-STAT and NF-κB signaling pathways.
    Jia Y; Jing J; Bai Y; Li Z; Liu L; Luo J; Liu M; Chen H
    PLoS One; 2011; 6(10):e27006. PubMed ID: 22066025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
    Zheng H; Zhang H; Liu F; Qi Y; Jiang H
    Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulation By Subchronic Low Dose 2,3,7,8-Tetrachlorodibenzo-p-Dioxin in Experimental Autoimmune Encephalomyelitis in the Absence of Pertussis Toxin.
    Yang EJ; Stokes JV; Kummari E; Eells J; Kaplan BL
    Toxicol Sci; 2016 May; 151(1):35-43. PubMed ID: 26822306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmenting DAF levels in vivo ameliorates experimental autoimmune encephalomyelitis.
    Li Q; Huang D; Nacion K; Bu H; Lin F
    Mol Immunol; 2009 Sep; 46(15):2885-91. PubMed ID: 19660813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-9 is important for T-cell activation and differentiation in autoimmune inflammation of the central nervous system.
    Li H; Nourbakhsh B; Cullimore M; Zhang GX; Rostami A
    Eur J Immunol; 2011 Aug; 41(8):2197-206. PubMed ID: 21674475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of myelin oligodendrocyte glycoprotein (MOG)35-55-specific CD8+ T cells in experimental autoimmune encephalomyelitis.
    Peng Y; Zhu FZ; Chen ZX; Zhou JX; Gan L; Yang SS; Gao S; Liu QQ
    Chin Med J (Engl); 2019 Dec; 132(24):2934-2940. PubMed ID: 31855963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-33 blockade suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Li M; Li Y; Liu X; Gao X; Wang Y
    J Neuroimmunol; 2012 Jun; 247(1-2):25-31. PubMed ID: 22516472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.